- Home
- INDV vs TARS Comparison
INDV vs TARS Comparison
Compare INDV & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDV
- TARS
- Stock Information
- Founded
- INDV 1994
- TARS 2016
- Country
- INDV United States
- TARS United States
- Employees
- INDV N/A
- TARS N/A
- Industry
- INDV Biotechnology: Pharmaceutical Preparations
- TARS Medicinal Chemicals and Botanical Products
- Sector
- INDV Health Care
- TARS Health Care
- Exchange
- INDV Nasdaq
- TARS Nasdaq
- Market Cap
- INDV 1.9B
- TARS 1.7B
- IPO Year
- INDV N/A
- TARS 2020
- Fundamental
- Price
- INDV $22.94
- TARS $51.82
- Analyst Decision
- INDV Strong Buy
- TARS Strong Buy
- Analyst Count
- INDV 4
- TARS 7
- Target Price
- INDV $20.75
- TARS $67.14
- AVG Volume (30 Days)
- INDV 4.5M
- TARS 662.2K
- Earning Date
- INDV 07-31-2025
- TARS 08-06-2025
- Dividend Yield
- INDV N/A
- TARS N/A
- EPS Growth
- INDV N/A
- TARS N/A
- EPS
- INDV 0.42
- TARS N/A
- Revenue
- INDV $1,173,000,000.00
- TARS $295,521,000.00
- Revenue This Year
- INDV N/A
- TARS $122.94
- Revenue Next Year
- INDV $3.00
- TARS $44.14
- P/E Ratio
- INDV $55.32
- TARS N/A
- Revenue Growth
- INDV 2.27
- TARS 254.45
- 52 Week Low
- INDV $7.33
- TARS $24.95
- 52 Week High
- INDV $23.12
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- INDV 90.68
- TARS 74.43
- Support Level
- INDV $21.83
- TARS $40.55
- Resistance Level
- INDV $16.34
- TARS $42.11
- Average True Range (ATR)
- INDV 0.77
- TARS 1.94
- MACD
- INDV 0.28
- TARS 1.20
- Stochastic Oscillator
- INDV 93.62
- TARS 96.24
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.